secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2022-11-22T23:59:59+00:00
Accession:  0001213900-22-074323
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed Pharmaceuticals raises ~$6M in private placement at $3.30/share, priced at premium to market
--------------------------------------------------------------------------------

- Raised ~$6M gross via sale of 1,818,185 shares/pre-funded warrants at $3.30 per share.
- Issued preferred investment options to buy up to 3,272,733 shares at $3.044/sh, expiring in 7 years.
- Investors cancelled prior options for ~1.38M shares, partially offsetting dilution.
- Placement agent H.C. Wainwright received options for 118,182 shares at $4.125/sh.
- Proceeds to fund pipeline development, manufacturing, IP, and general working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022074323/0001213900-22-074323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022074323/ea169087-8k_inmedpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-074323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer